Skip to main content
. 2014 Mar 26;35(8):1750–1759. doi: 10.1093/carcin/bgu078

Table VI.

Associations between IL genes and all-cause mortality and breast cancer-specific mortality

All women 0–28% NA ancestry 29–100% NA ancestry Interaction
Deaths/person year HRa (95% CI) Deaths/person year HRa (95% CI) Deaths/person year HRa (95% CI) P valueb
All-cause mortality
IL2RA (rs12244380)
    AA 167/7078 1.00 86/3933 1.00 81/3146 1.00 0.10
    AG 221/11058 0.84 (0.69, 1.03) 146/6551 0.98 (0.75, 1.28) 75/4507 0.66 (0.48, 0.90)
    GG 64/4325 0.61 (0.46, 0.81) 44/2772 0.70 (0.49, 1.01) 20/1553 0.46 (0.28, 0.75)
IL2RA (rs6602392)
    CC 335/17005 1.00 222/10427 1.00 113/6578 1.00 0.03
    CA/AA 117/5447 1.07 (0.86, 1.32) 54/2820 0.88 (0.65, 1.19) 63/2628 1.39 (1.02, 1.90)
IL2RA (rs791587)
    GG 110/6368 1.00 72/3603 1.00 38/2765 1.00 0.15
    GA/AA 342/16067 1.24 (1.00, 1.54) 204/9641 1.11 (0.85, 1.45) 138/6426 1.58 (1.10, 2.27)
IL2RA (rs706779)
    GG 134/6456 1.00 70/3115 1.00 64/3341 1.00 0.06
    GA 210/10780 0.96 (0.77, 1.19) 138/6232 1.05 (0.79, 1.41) 72/4548 0.81 (0.58, 1.14)
    AA 107/5207 0.99 (0.77, 1.29) 68/3894 0.81 (0.58, 1.13) 39/1312 1.57 (1.05, 2.35)
IL2RA (rs3118470)
    TT/TC 404/20427 1.00 250/11938 1.00 154/8489 1.00 0.04
    CC 48/2034 1.26 (0.94, 1.71) 26/1317 0.96 (0.64, 1.44) 22/717 1.88 (1.20, 2.95)
IL4 (rs2243250)
    CC 247/12156 1.00 186/9048 1.00 61/3109 1.00 0.88
    CT 145/8036 0.91 (0.73, 1.12) 71/3577 0.92 (0.70, 1.22) 74/4459 0.87 (0.62, 1.23)
    TT 50/1769 1.41 (1.01, 1.98) 12/293 2.23 (1.23, 4.03) 38/1476 1.23 (0.81, 1.87)
IL4 (rs2227282)
    CC/CG 367/18981 1.00 253/12516 1.00 114/6465 1.00 0.26
    GG 85/3472 1.30 (1.01, 1.68) 23/739 1.66 (1.08, 2.56) 62/2733 1.21 (0.88, 1.66)
IL4 (rs2243263)
    GG 333/17545 1.00 202/10624 1.00 131/6921 1.00 0.22
    GC/CC 119/4902 1.31 (1.06, 1.61) 74/2617 1.46 (1.12, 1.91) 45/2285 1.12 (0.79, 1.57)
IL6R (rs4075015)
    TT/TA 394/18804 1.00 239/10798 1.00 155/8007 1.00 0.31
    AA 58/3622 0.73 (0.55, 0.96) 37/2446 0.66 (0.47, 0.94) 21/1176 0.91 (0.57, 1.43)
IL6R (rs2229238)
    CC 248/13151 1.00 170/8146 1.00 78/5004 1.00 0.16
    CT/TT 141/6258 1.24 (1.01, 1.53) 94/4213 1.10 (0.86, 1.42) 47/2045 1.51 (1.05, 2.18)
Breast cancer-specific mortality
IL4 (rs2243263)
    GG 167/17545 1.00 98/10624 1.00 69/6921 1.00 0.32
    GC/CC 68/4902 1.49 (1.12, 1.98) 40/2617 1.69 (1.17, 2.45) 28/2285 1.27 (0.82, 1.98)
IL8 (rs4073)
    TT 73/7316 1.00 36/4121 1.00 37/3195 1.00 0.06
    TA 105/10944 1.00 (0.74, 1.35) 63/6343 1.20 (0.80, 1.82) 42/4601 0.82 (0.52, 1.28)
    AA 56/4188 1.37 (0.96, 1.94) 39/2791 1.80 (1.15, 2.84) 17/1397 0.92 (0.51, 1.65)
IL8 (rs2227307)
    TT 79/7789 1.00 37/4301 1.00 42/3488 1.00 0.04
    TG 102/10796 0.97 (0.72, 1.31) 63/6268 1.26 (0.83, 1.89) 39/4528 0.73 (0.47, 1.14)
    GG 54/3876 1.40 (0.99, 1.98) 38/2687 1.86 (1.18, 2.93) 16/1189 0.95 (0.52, 1.73)
IL8 (rs2227543)
    CC 88/9108 1.00 41/4808 1.00 47/4300 1.00 0.11
    CT 100/10161 1.04 (0.78, 1.38) 62/6058 1.29 (0.87, 1.93) 38/4103 0.81 (0.52, 1.25)
    TT 47/3164 1.65 (1.15, 2.37) 35/2362 1.98 (1.26, 3.12) 12/803 1.32 (0.69, 2.52)
IL17A (rs8193036)
    TT/TC 212/20884 1.00 126/12127 1.00 86/8757 1.00 0.01
    CC 22/1555 1.41 (0.90, 2.19) 11/1106 0.90 (0.49, 1.67) 11/448 2.90 (1.53, 5.49)
IL6R (rs4509570)
    CC 134/13678 1.00 88/7952 1.00 46/5726 1.00 0.02
    CG 101/8784 1.17 (0.90, 1.51) 50/5303 0.88 (0.62, 1.25) 51/3480 1.69 (1.13, 2.53)
IL6R (rs2229238)
    CC 129/13151 1.00 88/8146 1.00 41/5004 1.00 0.10
    CT/TT 71/6258 1.22 (0.91, 1.63) 42/4213 1.01 (0.70, 1.46) 29/2045 1.69 (1.05, 2.72)

aHR and 95% CI adjusted for age, study center, SEER stage and genetic ancestry.

bInteraction P value for G × genetic ancestry interaction.